Cargando…
Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity
A malignant solitary fibrous tumor arising from the omentum is extremely rare. To our knowledge, this is the first case of a malignant solitary fibrous omentum tumor coexisting with uterine corpus cancer. A 62-year-old woman presented to our hospital with vaginal discharge. Endometrioid adenocarcino...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120779/ https://www.ncbi.nlm.nih.gov/pubmed/25114818 http://dx.doi.org/10.1155/2014/216340 |
_version_ | 1782329142282289152 |
---|---|
author | Harada, Naoya Nobuhara, Ichiro Haruta, Noriko Higashiura, Yumi Watanabe, Hideki Ohno, Sumire |
author_facet | Harada, Naoya Nobuhara, Ichiro Haruta, Noriko Higashiura, Yumi Watanabe, Hideki Ohno, Sumire |
author_sort | Harada, Naoya |
collection | PubMed |
description | A malignant solitary fibrous tumor arising from the omentum is extremely rare. To our knowledge, this is the first case of a malignant solitary fibrous omentum tumor coexisting with uterine corpus cancer. A 62-year-old woman presented to our hospital with vaginal discharge. Endometrioid adenocarcinoma was diagnosed by endometrial curettage. In addition, a solid tumor in front of the uterus was detected following computed tomography and/or magnetic resonance imaging, which was suspected to be a primary (or secondary) malignant tumor arising from the omentum. Hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and lymphadenectomy were performed. A malignant solitary fibrous tumor of the omentum and grade 3 endometrioid adenocarcinoma of the uterus were diagnosed by pathohistological analysis. Interestingly, the tumor cells were immunoreactive for p53. Adjuvant chemotherapy was administered for the uterine corpus cancer and the patient remains healthy 48 months after the surgery. These tumors may have become malignant due to the presence of p53 mutations. |
format | Online Article Text |
id | pubmed-4120779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-41207792014-08-11 Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity Harada, Naoya Nobuhara, Ichiro Haruta, Noriko Higashiura, Yumi Watanabe, Hideki Ohno, Sumire Case Rep Obstet Gynecol Case Report A malignant solitary fibrous tumor arising from the omentum is extremely rare. To our knowledge, this is the first case of a malignant solitary fibrous omentum tumor coexisting with uterine corpus cancer. A 62-year-old woman presented to our hospital with vaginal discharge. Endometrioid adenocarcinoma was diagnosed by endometrial curettage. In addition, a solid tumor in front of the uterus was detected following computed tomography and/or magnetic resonance imaging, which was suspected to be a primary (or secondary) malignant tumor arising from the omentum. Hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and lymphadenectomy were performed. A malignant solitary fibrous tumor of the omentum and grade 3 endometrioid adenocarcinoma of the uterus were diagnosed by pathohistological analysis. Interestingly, the tumor cells were immunoreactive for p53. Adjuvant chemotherapy was administered for the uterine corpus cancer and the patient remains healthy 48 months after the surgery. These tumors may have become malignant due to the presence of p53 mutations. Hindawi Publishing Corporation 2014 2014-07-10 /pmc/articles/PMC4120779/ /pubmed/25114818 http://dx.doi.org/10.1155/2014/216340 Text en Copyright © 2014 Naoya Harada et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Harada, Naoya Nobuhara, Ichiro Haruta, Noriko Higashiura, Yumi Watanabe, Hideki Ohno, Sumire Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity |
title | Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity |
title_full | Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity |
title_fullStr | Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity |
title_full_unstemmed | Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity |
title_short | Concurrent Malignant Solitary Fibrous Tumor Arising from the Omentum and Grade 3 Endometrial Endometrioid Adenocarcinoma of the Uterus with p53 Immunoreactivity |
title_sort | concurrent malignant solitary fibrous tumor arising from the omentum and grade 3 endometrial endometrioid adenocarcinoma of the uterus with p53 immunoreactivity |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120779/ https://www.ncbi.nlm.nih.gov/pubmed/25114818 http://dx.doi.org/10.1155/2014/216340 |
work_keys_str_mv | AT haradanaoya concurrentmalignantsolitaryfibroustumorarisingfromtheomentumandgrade3endometrialendometrioidadenocarcinomaoftheuteruswithp53immunoreactivity AT nobuharaichiro concurrentmalignantsolitaryfibroustumorarisingfromtheomentumandgrade3endometrialendometrioidadenocarcinomaoftheuteruswithp53immunoreactivity AT harutanoriko concurrentmalignantsolitaryfibroustumorarisingfromtheomentumandgrade3endometrialendometrioidadenocarcinomaoftheuteruswithp53immunoreactivity AT higashiurayumi concurrentmalignantsolitaryfibroustumorarisingfromtheomentumandgrade3endometrialendometrioidadenocarcinomaoftheuteruswithp53immunoreactivity AT watanabehideki concurrentmalignantsolitaryfibroustumorarisingfromtheomentumandgrade3endometrialendometrioidadenocarcinomaoftheuteruswithp53immunoreactivity AT ohnosumire concurrentmalignantsolitaryfibroustumorarisingfromtheomentumandgrade3endometrialendometrioidadenocarcinomaoftheuteruswithp53immunoreactivity |